Effect of activated recombinant human factor 7 (Niastase) on laboratory testing of inhibitors of factors VIII and IX

Laboratory Hematology

Volumn 11, Issue 2, 2005, Pages 118-123

  Keeney, M ^a   Allan, D S ^a,b   Lohmann, R C ^a,c   Chin Yee, I H ^a,c  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Factor assay; Hemophilia; Inhibitor; Prothrombin time; rFVIIa

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 INHIBITOR; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING INHIBITOR; PROTHROMBIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBOPLASTIN;

ACCURACY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HEMOPHILIA A; HEMOPHILIA B; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LABORATORY TEST; PARTIAL THROMBOPLASTIN TIME; PATIENT MONITORING; PROTHROMBIN TIME; RELIABILITY; REPRODUCIBILITY;

ANTIBODIES; DRUG MONITORING; FACTOR IX; FACTOR VII; FACTOR VIII; FACTOR XII; HEMOPHILIA A; HEMOPHILIA B; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; PARTIAL THROMBOPLASTIN TIME; RECOMBINANT PROTEINS;

EID: 22144473641     PISSN: 10802924     EISSN: None     Source Type: Journal    
DOI: 10.1532/LH96.04048     Document Type: Article

References (19)

1. Hedner U. Recombinant coagulation factor VIIa: from the concept to clinical application in hemophilia treatment in 2000. Semin Thromb Hemost. 2000;26:363-366.
2. Hedner U. Recombinant activated factor VII as a universal haemostatic agent. Blood Coagul Fibrinolysis. 1998;9(suppl 1): S147-S152.
3. Erhardtsen E. Ongoing NovoSeven trials. Intensive Care Med. 2002;28(suppl 2):S248-S255.
4. Lloyd JV, Joist JH. Recombinant factor VIIa: a universal hemostatic agent? Curr Hematol Rep. 2002;1:19-26.
5. Butenas S, Brummel KE, Branda RF, Paradis SG, Mann KG. Mechanism of factor VIIa-dependent coagulation in hemophilia blood. Blood. 2002;99:923-930.
6. Hoffman M, Monroe DM 3rd, Roberts HR. Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII. Blood Coagul Fibrinolysis. 1998;9(suppl 1):S61-S65.
7. Hoffman M, Monroe DM, Roberts HR. Platelet-dependent action of high-dose factor VIIa. Blood. 2002;100:364-365.
8. Kasper CK, Aledort L, Aronson D, et al. Proceedings: a more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh. 1975;34:612.
9. Surudo T, Wojcicki M, Milkiewicz P, et al. Rapid correction of prothrombin time after low-dose recombinant factor VIIA in patients undergoing orthotopic liver transplantation. Transplant Proc. 2003;35:2323-2325.
10. Erhardtsen E, Nony P, Dechavanne M, Ffrench P, Boissel JP, Hedner U. The effect of recombinant factor VIIa (NovoSeven) in healthy volunteers receiving acenocoumarol to an international normalized ratio above 2.0. Blood Coagul Fibrinolysis. 1998;9:741-748.
11. Deveras RA, Kessler CM. Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate. Ann Intern Med. 2002;137:884-888.
12. Toffolon EP. Correcting PT with factor 7 may not improve clotting. Gastroenterology. 1998;115:800.
13. Hendriks HG, Meijer K, de Wolf JT, et al. Effects of recombinant activated factor VII on coagulation measured by thromboelastography in liver transplantation. Blood Coagul Fibrinolysis. 2002;13: 309-313.
14. Sorensen B, Johansen P, Christiansen K, Woelke M, Ingerslev J. Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. J Thromb Haemost. 2003;1:551-558.
15. Butenas S, Brummel KE, Bouchard BA, Mann KG. How factor VIIa works in hemophilia. J Thromb Haemost. 2003;1: 1158-1160.
16. Hoffman M, Monroe DM 3rd. The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis. Dis Mon. 2003; 49:14-21.
17. Gabriel DA, Li X, Monroe DM 3rd, Roberts HR. Recombinant human factor VIIa (rFVIIa) can activate factor FIX on activated platelets. J Thromb Haemost. 2004;2:1816-1822.
18. Tranholm M, Kristensen K, Kristensen AT, Pyke C, Rojkjaer R, Persson E. Improved hemostasis with superactive analogs of factor VIIa in a mouse model of hemophilia A. Blood. 2003;102: 3615-3620.
19. Friederich PW, Levi M, Bauer KA, et al. Ability of recombinant factor VIIa to generate thrombin during inhibition of tissue factor in human subjects. Circulation. 2001;103:2555-2559.